Jiuzhitang Co Ltd - Asset Resilience Ratio
Jiuzhitang Co Ltd (000989) has an Asset Resilience Ratio of 12.97% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Jiuzhitang Co Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Jiuzhitang Co Ltd's Asset Resilience Ratio has changed over time. See Jiuzhitang Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Jiuzhitang Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiuzhitang Co Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥648.00 Million | 12.97% |
| Total Liquid Assets | CN¥648.00 Million | 12.97% |
Asset Resilience Insights
- Moderate Liquidity: Jiuzhitang Co Ltd has 12.97% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Jiuzhitang Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiuzhitang Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910 |
Drug Manufacturers - Specialty & Generic | 11.95% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 16.92% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
Drug Manufacturers - Specialty & Generic | 5.22% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
Drug Manufacturers - Specialty & Generic | 6.02% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Hainan Honz Pharmaceutical Co
SHE:300086 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
Annual Asset Resilience Ratio for Jiuzhitang Co Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Jiuzhitang Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.76% | CN¥300.00 Million ≈ $43.90 Million |
CN¥5.21 Billion ≈ $762.60 Million |
+1.42pp |
| 2023-12-31 | 4.34% | CN¥231.20 Million ≈ $33.83 Million |
CN¥5.33 Billion ≈ $779.92 Million |
-1.60pp |
| 2020-12-31 | 5.94% | CN¥301.39 Million ≈ $44.10 Million |
CN¥5.07 Billion ≈ $742.12 Million |
-5.34pp |
| 2019-12-31 | 11.29% | CN¥553.58 Million ≈ $81.01 Million |
CN¥4.90 Billion ≈ $717.72 Million |
+7.87pp |
| 2018-12-31 | 3.41% | CN¥179.16 Million ≈ $26.22 Million |
CN¥5.25 Billion ≈ $767.94 Million |
+1.71pp |
| 2017-12-31 | 1.70% | CN¥100.00 Million ≈ $14.63 Million |
CN¥5.87 Billion ≈ $859.51 Million |
+1.64pp |
| 2010-12-31 | 0.06% | CN¥1.03 Million ≈ $150.35K |
CN¥1.74 Billion ≈ $254.40 Million |
0.00pp |
| 2009-12-31 | 0.06% | CN¥936.29K ≈ $137.01K |
CN¥1.55 Billion ≈ $226.45 Million |
-8.49pp |
| 2008-12-31 | 8.56% | CN¥132.28 Million ≈ $19.36 Million |
CN¥1.55 Billion ≈ $226.26 Million |
+7.85pp |
| 2007-12-31 | 0.70% | CN¥10.10 Million ≈ $1.48 Million |
CN¥1.44 Billion ≈ $210.96 Million |
-0.21pp |
| 2006-12-31 | 0.91% | CN¥12.56 Million ≈ $1.84 Million |
CN¥1.37 Billion ≈ $200.95 Million |
-5.04pp |
| 2005-12-31 | 5.95% | CN¥77.61 Million ≈ $11.36 Million |
CN¥1.30 Billion ≈ $190.72 Million |
+5.39pp |
| 2004-12-31 | 0.57% | CN¥7.61 Million ≈ $1.11 Million |
CN¥1.34 Billion ≈ $196.01 Million |
-0.29pp |
| 2003-12-31 | 0.86% | CN¥11.53 Million ≈ $1.69 Million |
CN¥1.34 Billion ≈ $195.70 Million |
+0.47pp |
| 2002-12-31 | 0.39% | CN¥3.95 Million ≈ $578.07K |
CN¥1.02 Billion ≈ $149.12 Million |
-- |
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more